Blue Trust Inc’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.46K Buy
+249
New +$7.07K ﹤0.01% 1936
2025
Q4
Sell
-10
Closed -$346 2615
2025
Q3
$346 Hold
10
﹤0.01% 2467
2025
Q2
$280 Hold
10
﹤0.01% 2363
2025
Q1
$251 Hold
10
﹤0.01% 2409
2024
Q4
$275 Sell
10
-508
-98% -$14.2K ﹤0.01% 2367
2024
Q3
$12.8K Buy
518
+247
+91% +$6.73K ﹤0.01% 2105
2024
Q2
$8.73K Buy
+271
New +$7.69K ﹤0.01% 1976
2024
Q1
Sell
-106
Closed -$4K 2405
2023
Q4
$4K Buy
+106
New +$3.9K ﹤0.01% 1914
2023
Q3
Sell
-4
Closed 2132
2023
Q2
$0 Sell
4
-7
-64% -$286 ﹤0.01% 2222
2023
Q1
$0 Sell
11
-38
-78% -$1.56K ﹤0.01% 2435
2022
Q4
$2K Buy
49
+26
+113% +$1.09K ﹤0.01% 1922
2022
Q3
$1K Buy
+23
New +$1.18K ﹤0.01% 1926

Other funds holding LKFT

Blue Trust Inc's LKFT Position: Q2 2026 in Review

Blue Trust Inc opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 249 shares worth $7.46K. The stake represents ﹤0.01% of the portfolio and ranks #1936 among its holdings. This is a return to the name: Blue Trust Inc previously reported a position in LKFT as recently as Q3 2025.

Blue Trust Inc first reported a position in LKFT in Q3 2022 and has held it in 12 quarters since. The position peaked at $12.8K in Q3 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Blue Trust Inc held 249 shares of Lakefront Biotherapeutics American Depositary Shares worth $7.46K as of Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Blue Trust Inc position in Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1936 holding.
  • Blue Trust Inc first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2022 and has held it in 12 quarters since.
  • Blue Trust Inc's Lakefront Biotherapeutics American Depositary Shares position peaked at $12.8K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.